Interpharm
(OTC) IPAH
Interpharm Financials at a Glance
Market Cap
$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$69.21M
Net Income (TTM)
-$29.36M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-575.10 (Low)
Dividend
$0.00
Beta (Volatility)
-575.10 (Low)
Price
$0.00
Volume
500
Open
$0.00
Price
$0.00
Volume
500
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
-575.10 (Low)
Price
$0.00
Volume
500
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
N/A
IPAH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Interpharm
IPAH Financials
Key Financial Metrics (TTM)
Gross Margin
28.66%
Operating Margin
-14.21%
Net Income Margin
-18.60%
Return on Equity
-82.09%
Return on Capital
-28.28%
Return on Assets
-18.90%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-0.88%
Stock Overview
Market Cap
$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
66.74M
Volume
500
Avg. Volume
986.484
Financials (TTM)
Gross Profit
$12.00M
Operating Income
-$19.72M
EBITDA
-$16.36M
Operating Cash Flow
-$21.75M
Capital Expenditure
-$7.86M
Free Cash Flow
-$29.61M
Cash & ST Invst.
$41.00K
Total Debt
$38.47M
Interpharm Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$16.21M
-7.2%
Gross Profit
$2.27M
-43.8%
Gross Margin
13.99%
N/A
Market Cap
$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.04
N/A
Employees
670
N/A
Net Income
-$10.90M
-164.2%
EBITDA
-$2.97M
+18.8%
Quarterly Fundamentals
Total Cash
$41.00K
-99.4%
Total Debt
$38.47M
+146.5%
Accounts Receivable
$13.72M
+20.9%
Inventory
$12.26M
+25.0%
Long Term Debt
$7.79M
-43.5%
Short Term Debt
$30.68M
+1597.0%
Return on Assets
-18.90%
N/A
Return on Invested Capital
-24.53%
N/A
Free Cash Flow
-$6.91M
-53.1%
Operating Cash Flow
-$6.35M
-96.2%